| 田振楠,韦 南,谭 雪,许明妍,吴荣祥.成功救治危重型新型冠状病毒肺炎患者1例的体会[J].,2021,(2):284-287 |
| 成功救治危重型新型冠状病毒肺炎患者1例的体会 |
| Experience of One Cases of Successfully Treated Patient with Critical Corona Virus Disease 2019 |
| 投稿时间：2020-05-22 修订日期：2020-06-17 |
| DOI：10.13241/j.cnki.pmb.2021.02.018 |
| 中文关键词: 新型冠状病毒肺炎 COVID-19 重型 危重型 |
| 英文关键词: Corona Virus Disease 2019 COVID-19 Severe Critical |
| 基金项目: |
|
| 摘要点击次数: 902 |
| 全文下载次数: 583 |
| 中文摘要: |
| 摘要 目的：总结危重型新型冠状病毒肺炎的临床特征和诊治方法，以期为该病的临床诊治提供参考依据。方法：回顾性分析华中科技大学同济医学院附属协和医院西院收治的一例危重型新型冠状病毒肺炎患者的临床资料，并结合相关文献总结危重型新型冠状病毒肺炎患者治疗经验。结果：危重型新型冠状病毒肺炎患者诊治过程中需规范抗炎、抗病毒治疗，选择正确的氧疗方式，着重关注患者的心理及营养问题，准确的评估静脉血栓栓塞症（venous thromboembolism，VTE）发生的风险，及时的预防和治疗VTE。结论：危重型新型冠状病毒肺炎不仅以肺为靶器官造成严重损害，还可能引发心脏、肠道、肾脏等多脏器损害，除常规抗炎、抗病毒、氧疗外，对患者的心理问题、营养问题及VTE的预防与治疗也同样重要。 |
| 英文摘要: |
| ABSTRACT Objective: Summarizing the clinical features, diagnose and treatment methods of critical corona virus disease 2019（COVID-19）, with a view to providing a reference for the clinical diagnoses and treatments of the disease. Methods: Retrospectively analyzing the clinical data of a patient with critical COVID-19 admitted to the West Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology(HUST). Results: During the diagnoses and treatments of patients with severe COVID-19, anti-inflammatory and anti-viral treatments should be standardized, correct oxygen therapy methods should be selected, the psychological and nutritional problems of the patients should be focused on attentively, the risk of VTE should be assessed accurately, and the preventions and treatments of venous thromboembolism（VTE）should be in time. Conclusion: Critical COVID-19 not only takes the lung as the target organ and causes damages to it, but also may do harms to multiple organs such as hearts, intestines, kidneys, etc. In addition to conventional anti-inflammatory, anti-viral, and oxygen therapies, psychological problems, nutritional issues and the preventions and treatments of VTE are equally important. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
